The Food and Drug Administration is considering loosening the rules for approving Alzheimer's drugs: Instead of having to demonstrate that their new drugs improve daily functioning, pharmaceutical companies can receive approval for drugs that simply show effectiveness in improving memory.
In other news, the Food and Drug Administration is considering loosening the rules for approving Alzheimer's drugs: Instead of having to demonstrate that their new drugs improve daily functioning, pharmaceutical companies can receive approval for drugs that simply show effectiveness in improving memory.
I'm sorry, that just never gets old!
**************************
Another current-events trope: Every article about the Papacy must mention that Benedict was the first Pope to resign in almost 600 years. More often than not, in an attempt to sound even more solemn, the phrase will be "nearly six centuries."
No comments:
Post a Comment